loading

Avalo Therapeutics Inc (AVTX) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
100.00%
-
0.571 0.236 0.643 0.475
Cost Of Revenue
63.80%
-0.08
-0.221 0.247 0.708 0.551
Costs And Expenses
298.19%
32.77
8.229 3.986 7.793 9.267
Operating Income/Loss
327.88%
-32.77
-7.658 -3.75 -7.15 -8.792
Nonoperating Income/Loss
16,955%
-88.52
-0.519 -1.47 -1.036 -1.155
Income/Loss From Continuing Operations Before Tax
1,383%
-121.28
-8.177 -5.22 -8.186 -9.947
Income Tax Expense/Benefit, Deferred
177.78%
0.007
-0.009 0.008 0.007 0.008
Income Tax Expense/Benefit
177.78%
0.007
-0.009 0.008 0.007 0.008
Income/Loss From Continuing Operations After Tax
1,385%
-121.29
-8.168 -5.228 -8.193 -9.955
Net Income/Loss
1,385%
-121.29
-8.168 -5.228 -8.193 -9.955
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
103.58%
0.8594
-24.00 46.76 13.97 11.72
Basic Earnings Per Share
24.73%
-141.00
-113.04 -0.11 -0.59 -0.85
Diluted Earnings Per Share
24.73%
-141.00
-113.04 -0.11 -0.59 -0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):